Targeting SNORA38B attenuates tumorigenesis and sensitizes immune checkpoint blockade in non-small cell lung cancer by remodeling the tumor microenvironment via regulation of GAB2/AKT/mTOR signaling pathway

Yue Zhuo(Wuhan University), Cheng‐Cao Sun(The University of Texas MD Anderson Cancer Center)
Journal for ImmunoTherapy of Cancer
May 1, 2022
Cited by 53


Related Papers